Finance
The Benchmark Company lifts AbCellera Biologics Inc [ABCL] price estimate. Who else is bullish?
AbCellera Biologics Inc [NASDAQ: ABCL] traded at a high on Wednesday, posting a 6.22 gain after which it closed the day’ session at $2.22. The results of the trading session contributed to over 4065614 shares changing hands. Over the past one week, the price volatility